000 01873 a2200517 4500
005 20250516180818.0
264 0 _c20140710
008 201407s 0 0 eng d
022 _a1872-9614
024 7 _a10.1016/j.nucmedbio.2013.09.010
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPickhard, Anja
245 0 0 _a²¹³Bi-anti-EGFR radioimmunoconjugates and X-ray irradiation trigger different cell death pathways in squamous cell carcinoma cells.
_h[electronic resource]
260 _bNuclear medicine and biology
_cJan 2014
300 _a68-76 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAlpha Particles
_xtherapeutic use
650 0 4 _aAntibodies, Monoclonal
_ximmunology
650 0 4 _aAntibody Specificity
650 0 4 _aApoptosis
_xradiation effects
650 0 4 _aBismuth
_xtherapeutic use
650 0 4 _aCarcinoma, Squamous Cell
_xpathology
650 0 4 _aCell Line, Tumor
650 0 4 _aErbB Receptors
_ximmunology
650 0 4 _aG1 Phase Cell Cycle Checkpoints
_xradiation effects
650 0 4 _aHead and Neck Neoplasms
_xpathology
650 0 4 _aHumans
650 0 4 _aImmunoconjugates
_xtherapeutic use
650 0 4 _aLinear Energy Transfer
650 0 4 _aRadioimmunotherapy
650 0 4 _aRadioisotopes
_xtherapeutic use
650 0 4 _aSignal Transduction
_xradiation effects
650 0 4 _aSurvival Analysis
650 0 4 _aX-Ray Therapy
700 1 _aPiontek, Guido
700 1 _aSeidl, Christof
700 1 _aKopping, Samuel
700 1 _aBlechert, Birgit
700 1 _aMißlbeck, Martin
700 1 _aBrockhoff, Gero
700 1 _aBruchertseifer, Frank
700 1 _aMorgenstern, Alfred
700 1 _aEssler, Markus
773 0 _tNuclear medicine and biology
_gvol. 41
_gno. 1
_gp. 68-76
856 4 0 _uhttps://doi.org/10.1016/j.nucmedbio.2013.09.010
_zAvailable from publisher's website
999 _c23247125
_d23247125